Skip to main content
. 2016 Sep 23;60(10):6134–6145. doi: 10.1128/AAC.00508-16

FIG 5.

FIG 5

PD simulations. (A) Exemplary simulation of mycobacterial counts in human lungs following QD oral administration of 600 mg INH for 2 days of treatment. Simulation results for an untreated immune-deficient (ID) patient, an untreated immunocompetent (IC) patient, and an immunocompetent INH-treated patient are shown. (B) Observed (23, 45) versus predicted EBA after 2 days of INH chemotherapy for slow, intermediate, and fast acetylators receiving QD INH doses ranging from 9 mg to 600 mg.